Community Research and Development Information Service - CORDIS

FP7 logo TBIcare

TBIcare

Project reference: 270259
Funded under: FP7-ICT

Evidence based Diagnostic and Treatment Planning Solution for Traumatic Brain Injuries [Print to PDF] [Print to RTF]

From 2011-02-01 to 2014-07-31

Project details

Total cost:

EUR 4 217 044

EU contribution:

EUR 3 158 000

Coordinated in:

Finland

Call for proposal:

FP7-ICT-2009-6

Funding scheme:

CP - Collaborative project (generic)

Traumatic brain injury (TBI) occurs when a sudden trauma causes damage to the brain – it is a major health problem and the most common cause of permanent disability in people under the age of 40 years. Yearly cost from TBI in Europe exceeds 100 billion euros. Recent statistics show a steep increase in the incidence of TBIs, with an increase of 21 % over the last five years – threefold greater than the rate of increase in population. Despite this TBI has been seriously underrepresented in medical R&D efforts.
The TBIcare project aims to improve TBI diagnostics and treatment decisions for every individual patient. To do that, the project researchers are developing a software solution to be used in daily practice. Part of this tool are 1) a methodology for finding efficient combinations of multi-modal biomarkers used in statistical models to objectively diagnose and assess a TBI patient, and 2) a simulation model for objectively predicting outcome of the planned treatment of a TBI patient.
TBIcare has impacts for healthcare professionals by improving the healthcare process and increasing medical knowledge; for the patients and their nearest by increased quality adjusted life years; for society it brings reduction in healthcare costs and losses due to working disability, and for the European industry it brings an impetus to increased global competitiveness by providing immediately exploitable innovative methods.

Objective

Traumatic brain injury (TBI) occurs when a sudden trauma causes damage to the brain – it is a major health problem and the most common cause of permanent disability in people under the age of 40 years. Yearly cost from TBI in Europe exceeds 100 billion euros. Recent statistics show a steep increase in the incidence of TBIs, with an increase of 21 % over the last five years – threefold greater than the rate of increase in population. Despite this TBI has been seriously underrepresented in medical R&D efforts compared to many other, less significant health problems.\nTBIcare project provides such an objective and evidence-based solution for management of TBI by improving diagnostics and treatment decisions for an individual patient. A strictly evidence-based approach realises the objectives of developing: 1) a methodology for finding efficient combinations of multi-modal biomarkers used in statistical models to objectively diagnose and assess an individual TBI patient, and 2) a simulation model for objectively predicting outcome of the planned treatment of an individual TBI patient. These objectives are supplemented by realization of: a software solution to be used in daily practice to diagnose and plan treatments; new approaches for extracting information from multi-source and multi-scale physiological databases for management of an extremely heterogeneous disease; and innovative data quantification methods for the clinical TBI environment. Thus, TBIcare transfers the scientific Virtual Physiological Human (VPH) concepts to clinical practice.\nTBIcare has impacts for healthcare professionals by improving the healthcare process and increasing medical knowledge; for the patients and their nearest by increased quality adjusted life years; for society it brings reduction in healthcare costs and losses due to working disability, and for the European industry it brings an impetus to increased global competitiveness by providing immediately exploitable innovative methods.

Related information

Documents and Publications

Open Access

Coordinator

TEKNOLOGIAN TUTKIMUSKESKUS VTT
Finland
Tekniikankatu 1
Tampere, Finland
Administrative contact: Jaana Heino
Tel.: +358 20 722 3301
Fax: +358 20 722 3499
E-mail

Participants

GE HEALTHCARE FINLAND OY
Finland
KUORTANEENKATU
HELSINKI, Finland
Administrative contact: Hanna Viertiö-Oja
Tel.: +358 40 504 8522
Fax: +358 40 504 8522
E-mail
VARSINAIS-SUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA
Finland
KIINAMYLLYNKATU 4-8
TURKU, Finland
Administrative contact: Olli Tenovuo
Tel.: +358504383802
Fax: +35823131164
E-mail
COMPLEXIO SARL
France
RUE DE STOCKHOLM
PARIS, France
Administrative contact: Valerie Gacogne
Tel.: +33 1 45 87 04 51
Fax: +33 9 58686743
E-mail
KAUNO TECHNOLOGIJOS UNIVERSITETAS
Lithuania
K DONELAICIO
KAUNAS, Lithuania
Administrative contact: Arminas Ragauskas
Tel.: +37068620084
Fax: +37037353807
E-mail
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
United Kingdom
The Old Schools, Trinity Lane
CAMBRIDGE, United Kingdom
Administrative contact: Renata Schaeffer
Tel.: +44 1223 333543
Fax: +44 1223 332988
E-mail
GE HEALTHCARE LIMITED
United Kingdom
AMERSHAM PLACE
LITTLE CHALFONT, United Kingdom
Administrative contact: Jan-Olof Berglund
Tel.: +46 18 666803
Fax: +46 18 666819
E-mail
IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE
United Kingdom
Exhibition Road, South Kensington Campus
LONDON, United Kingdom
Administrative contact: Shaun Power
Tel.: +44 20 7594 8773
Fax: +44 20 7594 8609
E-mail

Subjects

Life Sciences
Record Number: 97956 / Last updated on: 2014-09-09